ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

40.55
Delayed Data
As of May 22
 +0.33 / +0.82%
Today’s Change
19.15
Today|||52-Week Range
46.48
+27.72%
Year-to-Date

Today’s Trading

Previous close40.22
Today’s open40.29
Day’s range40.19 - 40.80
Volume802,654
Average volume (3 months)2,089,115
Market cap$4.0B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-41.99%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book13.00

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.13+0.40%
NBIXNeurocrine Bioscienc...+0.57+1.36%
HZNPHorizon Pharma PLC+1.50+4.91%
IPXLImpax Laboratories I...+0.75+1.65%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger G. Mills
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers